Imperatorin attenuates LPS-induced inflammation by suppressing NF-κB and MAPKs activation in RAW 264.7 macrophages.

Weixiao Guo, Jingjing Sun, Lanxiang Jiang, Lingxin Duan, Meixia Huo, Na Chen, Weiting Zhong, Lanan Wassy, Zhenguo Yang, Haihua Feng
Author Information
  1. Weixiao Guo: Department of Veterinary Pharmacology, College of Animal Science and Veterinary Medicine, Jilin University, Xi'an Road 5333, Changchun, Jilin 130062, People's Republic of China.

Abstract

Imperatorin is a type of coumarin compound with antibacterial and antiviral activities. In the present study, we examined the anti-inflammatory effects of imperatorin in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages by investigating its impact on the production and expression of cytokines and the major signal-transduction pathways. We found that imperatorin downregulated LPS-induced levels of TNF-α, IL-1β, and IL-6 in RAW 264.7 macrophages in a concentration-dependent manner, and it significantly inhibited expression of TNF-α and IL-6 (P < 0.05 or P < 0.01). The phosphorylation of mitogen-activated protein kinases and nuclear factor-kappaB (NF-κB) p65 protein were analyzed by western blotting. In RAW 264.7 macrophages treated with 1 mg/L of LPS, imperatorin significantly inhibited p38 and Jun N-terminal kinase phosphorylation protein expression. However, there was no significant change in p-ERK. Furthermore, imperatorin also inhibited NF-κB translocation into the nucleus through blockage of IκBα phosphorylation and degradation.

References

J Biol Chem. 1998 Oct 30;273(44):28670-6 [PMID: 9786861]
Biol Pharm Bull. 2010;33(6):1019-23 [PMID: 20522970]
Cancer Lett. 1999 Oct 18;145(1-2):151-7 [PMID: 10530783]
FASEB J. 1995 Jul;9(10):899-909 [PMID: 7542214]
Ann N Y Acad Sci. 2004 Dec;1030:1-13 [PMID: 15659775]
Eur Cytokine Netw. 1996 Apr-Jun;7(2):93-124 [PMID: 8688493]
Semin Immunol. 2000 Feb;12(1):85-98 [PMID: 10723801]
J Infect Dis. 1999 Apr;179(4):939-44 [PMID: 10068590]
J Surg Res. 2006 Aug;134(2):292-9 [PMID: 16519903]
J Biol Chem. 1997 Mar 21;272(12):8083-9 [PMID: 9065483]
Eur J Pharmacol. 2007 Nov 14;573(1-3):170-5 [PMID: 17662269]
Biomed Pharmacother. 2011 Dec;65(8):560-8 [PMID: 21194882]
Endocr Rev. 2001 Apr;22(2):153-83 [PMID: 11294822]
Nat Rev Immunol. 2002 Oct;2(10):787-95 [PMID: 12360216]
Shock. 2005 Sep;24(3):206-9 [PMID: 16135957]
Oncogene. 2006 Oct 30;25(51):6680-4 [PMID: 17072321]
J Appl Physiol (1985). 2007 Jul;103(1):388-95 [PMID: 17303713]
Cell Signal. 1999 Jul;11(7):491-7 [PMID: 10405759]
Cytokine. 2008 May;42(2):145-151 [PMID: 18304834]
Curr Opin Immunol. 2010 Feb;22(1):20-7 [PMID: 20060278]
Neurobiol Dis. 2006 May;22(2):445-51 [PMID: 16480888]
J Exp Med. 1999 Jun 7;189(11):1777-82 [PMID: 10359581]
J Biol Chem. 2000 Jul 7;275(27):20260-7 [PMID: 10751418]
J Biol Chem. 2004 Sep 3;279(36):37349-59 [PMID: 15218031]
Nat Rev Immunol. 2002 Oct;2(10):725-34 [PMID: 12360211]
Planta Med. 2003 May;69(5):408-12 [PMID: 12802720]
Annu Rev Immunol. 1996;14:649-83 [PMID: 8717528]
J Neuroinflammation. 2011 Aug 10;8:95 [PMID: 21831303]
Food Chem Toxicol. 2010 May;48(5):1222-9 [PMID: 20156520]
Bioorg Med Chem. 2008 Sep 15;16(18):8390-6 [PMID: 18786831]
J Immunol. 1991 May 15;146(10):3444-51 [PMID: 1827484]

MeSH Term

Animals
Anti-Inflammatory Agents
Cell Line
Cell Survival
Enzyme Activation
Furocoumarins
I-kappa B Kinase
Inflammation
Inflammation Mediators
Interleukin-1beta
Interleukin-6
JNK Mitogen-Activated Protein Kinases
Lipopolysaccharides
Macrophages
Mice
Mitogen-Activated Protein Kinases
NF-kappa B
Phosphorylation
Protein Transport
Transcription Factor RelA
Tumor Necrosis Factor-alpha
p38 Mitogen-Activated Protein Kinases

Chemicals

Anti-Inflammatory Agents
Furocoumarins
Inflammation Mediators
Interleukin-1beta
Interleukin-6
Lipopolysaccharides
NF-kappa B
Rela protein, mouse
Transcription Factor RelA
Tumor Necrosis Factor-alpha
I-kappa B Kinase
JNK Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinases
p38 Mitogen-Activated Protein Kinases
imperatorin

Word Cloud

Similar Articles

Cited By